Allergan Stockholders Seek Class Status in Stock Drop Lawsuit

Allergan investors want class status in securities litigation alleging the health-care company misled them about the “safety and regulatory status” of its textured breast implants, according to filings in the Southern District of New York.

Lead plaintiff DeKalb County Pension Fund’s Thursday motion says that it seeks to represent a proposed class comprising of anyone who acquired Allergan securities between Jan. 30, 2017, and Dec. 19, 2018.

The December date is when Allergan stock dropped $10.20, closing at $136.56, and one day after France’s National Agency for the Safety of Medicines & Health Products ordered a recall of its textured ...